Noh Hyunjin, Ha Hunjoo, Yu Mi Ra, Kang Shin Wook, Choi Kyu Hun, Han Dae Suk, Lee Ho Yung
Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Nephron. 2002 Jan;90(1):78-85. doi: 10.1159/000046318.
BACKGROUND/AIM: Increased nitric oxide (NO) generation and action have been suggested to be associated with glomerular hyperfiltration and increased vascular permeability early in diabetes. However, previous studies have primarily focused on the constitutive nitric oxide synthase (cNOS) pathway present in endothelial cells, and the role of the inducible NOS (iNOS) pathway in diabetic nephropathy has remained unclear. This study examined whether high glucose modulates NO synthesis by the iNOS pathway in rat mesangial cells. In addition, the effect of inhibition of the iNOS pathway on fibronectin production was determined to examine the role of the iNOS pathway in high glucose-induced extracellular expansion by mesangial cells.
NO synthesis by the iNOS pathway was evaluated by nitrite and iNOS mRNA and protein productions. The effects of protein kinase C (PKC) inhibitor and aldose reductase inhibitor on the iNOS mRNA expression and aminoguanidine, a relatively specific inhibitor of the iNOS on fibronectin protein production were examined.
High 30 mM glucose concentration led to significant increases in nitrite production of rat mesangial cells upon stimulation with lipopolysaccharide (LPS) plus interferon-gamma (IFN-gamma) compared with control 5.6 mM glucose concentration. Mesangial iNOS mRNA expression and protein production also increased significantly in response to high glucose. The addition of calphostin C, a PKC inhibitor, and 6-bromo-1,3-dioxo-1H-benz[d,e]isoquinoline-2(3H)-acetic acid, an aldose reductase inhibitor, significantly suppressed the enhancement of iNOS mRNA expression in high glucose concentration. High glucose also significantly increased fibronectin protein production of mesangial cells upon stimulation with LPS plus IFN-gamma compared to control glucose. Aminoguanidine reversed this high glucose-induced fibronectin production at dose inhibiting iNOS mRNA expression.
These results indicate that high glucose enhances cytokine-induced NO production by rat mesangial cells, and that the activation of PKC and aldose reductase pathway may play a role in this enhancement. In addition, high glucose-induced NO production by the iNOS pathway may promote extracellular matrix accumulation by mesangial cells under certain condition.
背景/目的:一氧化氮(NO)生成和作用增加被认为与糖尿病早期的肾小球高滤过和血管通透性增加有关。然而,以往研究主要集中在内皮细胞中存在的组成型一氧化氮合酶(cNOS)途径,诱导型一氧化氮合酶(iNOS)途径在糖尿病肾病中的作用仍不明确。本研究探讨高糖是否通过iNOS途径调节大鼠系膜细胞中NO的合成。此外,通过测定抑制iNOS途径对纤连蛋白产生的影响,来研究iNOS途径在高糖诱导的系膜细胞细胞外扩张中的作用。
通过亚硝酸盐以及iNOS mRNA和蛋白的产生来评估iNOS途径的NO合成。研究了蛋白激酶C(PKC)抑制剂和醛糖还原酶抑制剂对iNOS mRNA表达的影响,以及氨基胍(一种相对特异性的iNOS抑制剂)对纤连蛋白蛋白产生的影响。
与对照的5.6 mM葡萄糖浓度相比,30 mM高糖浓度导致脂多糖(LPS)加干扰素-γ(IFN-γ)刺激后大鼠系膜细胞亚硝酸盐产生显著增加。系膜细胞iNOS mRNA表达和蛋白产生在高糖刺激下也显著增加。添加PKC抑制剂钙泊三醇C和醛糖还原酶抑制剂6-溴-1,3-二氧代-1H-苯并[d,e]异喹啉-2(3H)-乙酸可显著抑制高糖浓度下iNOS mRNA表达的增强。与对照葡萄糖相比,高糖在LPS加IFN-γ刺激下也显著增加系膜细胞纤连蛋白蛋白的产生。氨基胍在抑制iNOS mRNA表达的剂量下可逆转这种高糖诱导的纤连蛋白产生。
这些结果表明,高糖增强细胞因子诱导的大鼠系膜细胞NO产生,PKC和醛糖还原酶途径的激活可能在这种增强中起作用。此外,在某些条件下,iNOS途径介导的高糖诱导的NO产生可能促进系膜细胞细胞外基质的积累。